UAE Peptide Prices 2026: Complete Market Guide

One of the most common questions people ask before starting GLP-1 or peptide therapy in the UAE is simply: what does it cost? Prices vary widely between clinics, and a lack of transparency can make it hard to judge whether a quote is fair. This guide sets out indicative 2026 ranges, explains what actually drives the cost, and shows why price transparency is a signal of a trustworthy provider. All figures are indicative only and change over time — always confirm the current total with the clinic.

Indicative price ranges (2026)

For the most-searched GLP-1 medicines, indicative monthly medication costs currently sit around AED 780–950 per month for semaglutide (Ozempic/Wegovy) and broadly in a similar-to-higher band for tirzepatide (Mounjaro/Zepbound), depending on dose and availability. On top of the medication, an initial physician consultation is commonly AED 350–700, and baseline bloodwork typically runs AED 400–1,200. Some clinics offer bundled monthly programs — combining consultation, medication and monitoring — which can range higher, often AED 2,500–5,000 per month depending on what is included.

See our full, itemised UAE pricing breakdown by treatment →

Other peptides used in physician-supervised settings vary considerably, and many discussed online have no legitimate, approved retail price in the UAE at all because they are not approved human medicines. Where a compound is not an approved medicine, the absence of a normal price is itself a red flag rather than a bargain to be hunted down.

What actually drives the cost

Several factors shape the number you are quoted. The medication itself is the biggest component, and it is priced by dose — higher maintenance doses cost more. The clinic model matters too: a bundled program that includes unlimited follow-ups, coaching and monitoring will cost more than medication alone, but it may represent better value if you use those services. Location, brand availability and whether bloodwork is included all move the total. Genuine, licensed, cold-chain-stored medication has a real floor price, which is why quotes far below the market range should raise suspicion rather than excitement.

Why price transparency matters

A clinic that states its prices clearly — medication, consultation, bloodwork and follow-up — is easier to trust than one that keeps the total vague until you are committed. Transparency also lets you compare like with like. A cheaper headline price that excludes consultation and monitoring is not actually cheaper; it just hides the cost. And a price that is dramatically below everyone else usually means the supply is not what it claims to be. In a market where counterfeit and unlicensed GLP-1 products exist, a fair, transparent price from a licensed clinic is a feature, not a premium.

Compare treatments side by side to see what fits your goals and budget →

The bottom line

Expect GLP-1 medication in the UAE to sit broadly in the AED 780–950 per month range for semaglutide, plus consultation and bloodwork, with bundled programs costing more. Judge a quote by its transparency and by whether it comes from a licensed clinic — not by whether it is the lowest number you can find. The cheapest option is rarely the safest, and with injectable medicines, safety is the whole point.